Joint Formulary & PAD

Peptac - Dyspepsia

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green (see narrative)
Formulations :
  • Suspension
Associated Icons :
Restrictions / Comments :
Important
RSCH use in children age 6-12 years only.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Peptac
Indication :
Dyspepsia
Group Name :
Keywords :
Sodium alginate, acid reflux, heartburn, reflux oesophagitis, GORD, Indigestion, Gastro oesophageal reflux disorder, compound alginates
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Peptac is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Dyspepsia.

Committee Recommendations (1)

This drug has been agreed as appropriate for initiation in Primary Care and/or continued in Primary Care following a recommendation from specialists in other health care sectors. Following consideration by the PCN, it has been assigned a GREEN traffic light status.